Skip to content
10-Q

Quarterly Report

TALON THERAPEUTICS, INC.

0001437749-12-005027

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 14, 2012 21.89M sh
Stockholders Equity Q1 2012 · Mar 31, 2012 −$89.13M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$59.02M
Current Liabilities Q1 2012 · Mar 31, 2012 $3.08M
Current Liabilities Q1 2012 · Dec 31, 2011 $4.56M
Total Liabilities Q1 2012 · Mar 31, 2012 $62.24M
Total Liabilities Q1 2012 · Dec 31, 2011 $30.87M
Current Assets Q1 2012 · Mar 31, 2012 $7.02M
Current Assets Q1 2012 · Dec 31, 2011 $1.66M
Total Assets Q1 2012 · Mar 31, 2012 $7.77M
Total Assets Q1 2012 · Dec 31, 2011 $2.49M
Shares Diluted Q1 2012 · Mar 31, 2011 21.24M sh
Capex Q1 2012 · Mar 31, 2011 $66K
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$6.34M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $9.17M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $4.57M
Eps Diluted Q1 2012 · Mar 31, 2011 −$0.53
Sga Expense Q1 2012 · Mar 31, 2011 $1.48M
Rd Expense Q1 2012 · Mar 31, 2011 $5.14M
Net Income Q1 2012 · Mar 31, 2011 −$10.42M
Operating Income Q1 2012 · Mar 31, 2011 −$6.62M